HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) Revenue growth
HealthEquity, Inc.'s revenue growth over the twelve months to 31 July 2026 was 7.34%, down 2.1 percentage points from fiscal 2026 (9.47%). Over the past ten years it has ranged from 3.13% (fiscal 2022) to 85.2% (fiscal 2020); the current reading is higher than 17% of that period. That is above the Health Information Services industry median of 6.48% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 9.47% | (10.56) |
| FY2025 | 20.0% | 4.03 |
| FY2024 | 16.0% | 2.10 |
| FY2023 | 13.9% | 10.77 |
| FY2022 | 3.13% | (34.76) |
| FY2021 | 37.9% | (47.32) |
| FY2020 | 85.2% | 60.06 |
| FY2019 | 25.2% | (3.53) |
| FY2018 | 28.7% | (12.01) |
| FY2017 | 40.7% | (3.62) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jul 2026 | 7.64% | 0.45 |
| Apr 2026 | 7.19% | (0.11) |
| Jan 2026 | 7.30% | 0.07 |
| Oct 2025 | 7.23% | (1.41) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| HNGE Hinge Health Inc. compare | 58.8% |
| HTFL Heartflow, Inc. compare | 42.8% |
| TEM Tempus AI, Inc. compare | 36.6% |
| BTSG BrightSpring Health Services, Inc. compare | 26.0% |
| WAY Waystar Holding Corp. compare | 21.4% |
| PRVA Privia Health Group, Inc. compare | 19.2% |
| HQY HealthEquity, Inc. | 7.34% |
| DOCS Doximity, Inc. compare | 6.48% |
| SDGR Schrodinger, Inc. compare | 4.77% |
| Health Information Services industry median | 6.48% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on HQY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement